Table 1 Patient and disease characteristics
| # | (%) | [range] | |
|---|---|---|---|
| Number of patients | 32 | ||
| Male | 14 | (40%) | |
| Female | 19 | (60%) | |
| Median age on starting tamoxifen | 41 | [19–68] | |
| Site of origin | |||
| Extremities (including girdle) | 18 | (56%) | |
| Chest wall | 5 | (15%) | |
| Pelvis | 3 | (10%) | |
| Abdominal wall | 3 | (10%) | |
| Paravertebral | 1 | (3%) | |
| Head and neck | 2 | (6%) | |
| Sporadic disease | 31 | (97%) | |
| FAP-associated | 1 | (3%) | |
| Previous treatments | 18 | (56%) | |
| Local treatment | |||
| Surgery | 10 | (31%) | |
| Surgery and RT | 7 | (21%) | |
| RT alone | 0 | ||
| Systemic treatment | 4 | (12%) | |
| No previous treatment | 14 | (44%) | |